Bupathi, M., Ahn, D. H., Wu, C., Ciombor, K. K., Stephens, J. A., Reardon, J., . . . Bekaii-Saab, T. (2016). Modified irinotecan and infusional 5-fluorouracil (mFOLFIRI) in patients with refractory advanced pancreas cancer (APC): A single-institution experience. Med Oncol.

Bupathi, M., D. H. Ahn, C. Wu, K. K. Ciombor, J. A. Stephens, J. Reardon, D. A. Goldstein, and T. Bekaii-Saab. "Modified Irinotecan and Infusional 5-fluorouracil (mFOLFIRI) in Patients With Refractory Advanced Pancreas Cancer (APC): A Single-institution Experience." Med Oncol 2016.

Bupathi, M., et al. "Modified Irinotecan and Infusional 5-fluorouracil (mFOLFIRI) in Patients With Refractory Advanced Pancreas Cancer (APC): A Single-institution Experience." Med Oncol 2016.